These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31308487)

  • 1. Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains.
    Berg KCG; Sveen A; Høland M; Alagaratnam S; Berg M; Danielsen SA; Nesbakken A; Søreide K; Lothe RA
    Oncogene; 2019 Aug; 38(33):6109-6122. PubMed ID: 31308487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus molecular subtype classification of colorectal adenomas.
    Komor MA; Bosch LJ; Bounova G; Bolijn AS; Delis-van Diemen PM; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; van Grieken NC; Carvalho B; Wessels LF; Jimenez CR; Fijneman RJ; Meijer GA;
    J Pathol; 2018 Nov; 246(3):266-276. PubMed ID: 29968252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiles in genome instability-based classes of colorectal cancer.
    Barresi V; Cinnirella G; Valenti G; Spampinato G; Musso N; Castorina S; Condorelli DF
    BMC Cancer; 2018 Dec; 18(1):1265. PubMed ID: 30563495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionally-focused algorithmic analysis of high resolution microarray-CGH genomic landscapes demonstrates comparable genomic copy number aberrations in MSI and MSS sporadic colorectal cancer.
    Ali H; Bitar MS; Al Madhoun A; Marafie M; Al-Mulla F
    PLoS One; 2017; 12(2):e0171690. PubMed ID: 28231327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer.
    Smeby J; Sveen A; Merok MA; Danielsen SA; Eilertsen IA; Guren MG; Dienstmann R; Nesbakken A; Lothe RA
    Ann Oncol; 2018 May; 29(5):1227-1234. PubMed ID: 29518181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
    Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
    Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.
    Lassmann S; Weis R; Makowiec F; Roth J; Danciu M; Hopt U; Werner M
    J Mol Med (Berl); 2007 Mar; 85(3):293-304. PubMed ID: 17143621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite stable colorectal cancers stratified by the BRAF V600E mutation show distinct patterns of chromosomal instability.
    Bond CE; Nancarrow DJ; Wockner LF; Wallace L; Montgomery GW; Leggett BA; Whitehall VL
    PLoS One; 2014; 9(3):e91739. PubMed ID: 24651849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathological classification of colorectal cancer.
    Müller MF; Ibrahim AE; Arends MJ
    Virchows Arch; 2016 Aug; 469(2):125-34. PubMed ID: 27325016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations.
    Xie T; D' Ario G; Lamb JR; Martin E; Wang K; Tejpar S; Delorenzi M; Bosman FT; Roth AD; Yan P; Bougel S; Di Narzo AF; Popovici V; Budinská E; Mao M; Weinrich SL; Rejto PA; Hodgson JG
    PLoS One; 2012; 7(7):e42001. PubMed ID: 22860045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component.
    Alonso MH; Aussó S; Lopez-Doriga A; Cordero D; Guinó E; Solé X; Barenys M; de Oca J; Capella G; Salazar R; Sanz-Pamplona R; Moreno V
    Br J Cancer; 2017 Jul; 117(3):421-431. PubMed ID: 28683472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer.
    Loo LW; Tiirikainen M; Cheng I; Lum-Jones A; Seifried A; Church JM; Gryfe R; Weisenberger DJ; Lindor NM; Gallinger S; Haile RW; Duggan DJ; Thibodeau SN; Casey G; Le Marchand L
    Genes Chromosomes Cancer; 2013 May; 52(5):450-66. PubMed ID: 23341073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide differences between microsatellite stable and unstable colorectal tumors.
    Camps J; Armengol G; del Rey J; Lozano JJ; Vauhkonen H; Prat E; Egozcue J; Sumoy L; Knuutila S; Miró R
    Carcinogenesis; 2006 Mar; 27(3):419-28. PubMed ID: 16272173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies.
    Berg KCG; Eide PW; Eilertsen IA; Johannessen B; Bruun J; Danielsen SA; Bjørnslett M; Meza-Zepeda LA; Eknæs M; Lind GE; Myklebost O; Skotheim RI; Sveen A; Lothe RA
    Mol Cancer; 2017 Jul; 16(1):116. PubMed ID: 28683746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
    Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
    Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA copy number profiling in microsatellite-stable and microsatellite-unstable hereditary non-polyposis colorectal cancers by targeted CNV array.
    Chen W; Ding J; Jiang L; Liu Z; Zhou X; Shi D
    Funct Integr Genomics; 2017 Jan; 17(1):85-96. PubMed ID: 27896456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies.
    Sveen A; Bruun J; Eide PW; Eilertsen IA; Ramirez L; Murumägi A; Arjama M; Danielsen SA; Kryeziu K; Elez E; Tabernero J; Guinney J; Palmer HG; Nesbakken A; Kallioniemi O; Dienstmann R; Lothe RA
    Clin Cancer Res; 2018 Feb; 24(4):794-806. PubMed ID: 29242316
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
    Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD
    J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genome-wide study of the relationship between chromosomal abnormalities and gene expression in colorectal tumors.
    Sugai T; Osakabe M; Sugimoto R; Eizuka M; Tanaka Y; Yanagawa N; Otsuka K; Sasaki A; Matsumoto T; Suzuki H
    Genes Chromosomes Cancer; 2021 Apr; 60(4):250-262. PubMed ID: 33258187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers.
    Jorissen RN; Lipton L; Gibbs P; Chapman M; Desai J; Jones IT; Yeatman TJ; East P; Tomlinson IP; Verspaget HW; Aaltonen LA; Kruhøffer M; Orntoft TF; Andersen CL; Sieber OM
    Clin Cancer Res; 2008 Dec; 14(24):8061-9. PubMed ID: 19088021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.